Burden

Apr 10, 2017

Disease Burden of Systemic Light-Chain Amyloidosis: A Systematic Literature Review

Introduction: A systematic literature review on systemic light chain (AL) amyloidosis was conducted in order to understand the disease burden, and identify unmet…

Inotersen: An Exciting Prospect for hATTR Amyloidosis Treatment

Subscribe to

Expert and Community Perspectives on Attruby®

In this special session, Dr. Barry Trachtenberg and members of the ATTR amyloidosis community came together to share medical insights and lived experiences related to Attruby™ (acoramidis). This expert-led discussion explores the clinical data, the patient perspective, and what lies ahead for those considering or currently taking Attruby.